Trazodone in burning mouth pain: a placebo-controlled, double-blind study

J Orofac Pain. 1999 Spring;13(2):83-8.

Abstract

Aims: An 8-week parallel, placebo-controlled, double-blind trial evaluated the efficacy of the antidepressant trazodone in the treatment of chronic burning mouth pain.

Methods: Thirty-seven carefully selected women aged 39 to 71 (mean 58.6 years) were randomized to receive either 200 mg of trazodone or a placebo in a similar manner. Pain and pain-related symptoms were evaluated on a visual analogue scale and other measures at 0, 2, 4, and 8 weeks.

Results: There were no significant differences between the groups in treatment effects for pain or pain-related symptoms. Seven patients in the trazodone group and 2 in the placebo group failed to complete the trial because of side effects. The most common side effects were dizziness and drowsiness.

Conclusion: In this controlled trial, trazodone failed to relieve burning mouth pain.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Burning Mouth Syndrome / drug therapy*
  • Chronic Disease
  • Double-Blind Method
  • Facial Pain / drug therapy
  • Female
  • Humans
  • Middle Aged
  • Pain Measurement
  • Trazodone / therapeutic use*
  • Treatment Failure

Substances

  • Antidepressive Agents, Second-Generation
  • Trazodone